Lymfadenopathie bij kinderen

• Opfrissen kennis omtrent differentiaal diagnose van lymfadenopathie bij kinderen
• Waarde van aanvullende diagnostiek bij lymfadenopathie bij kinderen
• Argumenten waarmee aanvullende diagnostiek bij lymfadenopathie doelmatig kan worden ingezet

Speakers

• 

  Farah A. Falix - kinderarts-nefroloog

  Farah Falix was born in Paramaribo in 1977. She grew up there and followed part of her secondary school education at the J.C.de Miranda Lyceum in Paramaribo. In 1993 she emigrated to the Netherlands together with her family and graduated from the Amstel Lyceum Amsterdam in 1994. She first studied Medical Biology at the Free University of Amsterdam (VUmc) and  obtained her doctorate degree in Medical Biology in 1997. In that same year she was allotted for Medicine at the same University, where she obtained her medical degree in January 2002. She began working as a resident at the department of Pediatric Surgery in the Academic Medical Center of Amsterdam (AMC) and initiated a research project on the role of DLK1 in the development of the pediatric liver tumor hepatoblastoma, at the Tytgat Institute for Liver and Intestinal Research, AMC. With her research proposal she obtained a Mozaïek grant from the Netherlands Organization for Scientific Research (NWO) in 2004, which resulted in her PhD degree in 2012. Meanwhile from April 2007 she also started her pediatrics specialization  at the Emma Children’s Hospital AMC. Also in 2007 Farah happily married her medical biology-lover Marijn Bögels and one year later their daughter Isabel was born. In 2014 she obtained her pediatric specialization at Emma Children’s Hospital Amsterdam, after which she subspecialized in pediatric nephrology until 2017, whereafter she decided to emigrate to beautiful Curaçao and has been working as both pediatric nephrologist and general pediatrician since then. Her main side tasks are: educational coordinator of the CMC pediatric department, member of the daily board of the COCC (centrale opleidingscommissie CMC) and member of the medicines committee CMC.